AUPH
Aurinia Pharmaceuticals Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +0.7% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 27.85K | $451,566 | n/a | −1 |
| Q2 2026 | 100 | +2 | 47.31M | $802.51M | +6 | −5 |
| Q1 2026 | 102 | +4 | 44.87M | $664.75M | +6 | −2 |
| Q4 2025 | 99 | 0 | 44.16M | $700.36M | n/a | n/a |
| Q3 2025 | 19 | 0 | 27.17M | $300.26M | n/a | n/a |
| Q2 2025 | 16 | +1 | 17.49M | $148.13M | +1 | n/a |
| Q1 2025 | 12 | 0 | 8.38M | $67.38M | +1 | −1 |
| Q4 2024 | 12 | +2 | 8.32M | $74.71M | +3 | −1 |
| Q3 2024 | 9 | 0 | 3.64M | $26.69M | n/a | n/a |
| Q2 2024 | 9 | n/a | 3.40M | $19.43M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 2.85M | -2.3% | $22.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.73M | -1.7% | $13.94M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 3 | Arrowstreet Capital ✦ | 1.64M | +52.5% | $13.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 938.60K | +33.9% | $7.55M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 503.54K | +8.7% | $4.05M | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
| 6 | D. E. Shaw & Co. ✦ | 264.42K | +98.3% | $2.13M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 120.98K | -28.2% | $972,655 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 106.89K | New | $859,380 | 0.0% | New | 1 | SEC ↗ |
| 9 | Gotham Asset Management ✦ | 83.04K | +84.5% | $667,609 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 59.04K | +13.3% | $475,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 55.19K | -9.2% | $443,727 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 12 | Millennium Management ✦ | 22.57K | -74.2% | $181,503 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Two Sigma Investments | $859,380 | 0.0% |
Exited
| Point72 Asset Management | $7.63M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 256 holders, 73.58M shares, $1.06B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 11.94K sh · $190,427
Officer · 20.98K sh · $355,946
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
3.7% of class · View original SEC filing ↗
10.0% of class · View original SEC filing ↗